| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT05503797 | A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer… | Cancer Harboring BRAF Alterations | Recruiting | 2026-07-27 |
Bladder Cancer (1) · Breast Cancer (1) · Cholangiocarcinoma (1) · Glioma (1) · Liver Cancer (1) · Ovarian Cancer (1)